glp 1 cholesterol GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Frontiers | GLP-1-Induced AMPK Activation
Description
Some GLP-1 drug formulations are used to treat type 2 diabetes, and Medicaid must cover them nationwide

This model suggests that antitumor effects may be dependent on concurrent administration and not mediated solely by weight loss

doi:10.1002/14651858.CD012906.pub2

GLP-1RA and GIP/GLP-1RA, although structurally similar to endogenous incretins, are resistant to inactivation by DPP-4, which prolongs their effects (Figure 1)
Back Lay, K (28 March 2024) 'Study: 'gamechanger' diabetes drugs cost up to 400 times more than needed', The Guardian
Their broad metabolic effects make them valuable tools for tackling complex metabolic syndromes
